Jingyu Wang
Chairman of the Board
Director since December 2022 and the company's Chief Executive Officer from December 2022 to December 2025, having advised the company on its initial public offering and public disclosures from 2021. Since October 2024 he has been a director and secretary of the board of Hangzhou Tangji Medical Technology Co., Ltd. From 2015 to 2021 he served as secretary of the board at 36Kr Holdings Inc. (Nasdaq: KRKR), coordinating the company's public disclosures. He holds a bachelor's degree in law from the China University of Political Science and Law.